Biomedical Catalyst funding gives boost to healthcare innovation.

Thirty three projects, including the project we described in our post from 22/5/25, will receive funding from Innovate UK Biomedical Catalyst (BMC) to help them translate their ideas into products and therapies for patients, bringing them a step closer to commercialisation.

The BMC is Innovate UK’s flagship funding programme, designed to accelerate the growth of the UK’s most promising health and life sciences businesses. It empowers innovative small and medium-sized enterprises (SMEs) to develop, test and commercialise cutting-edge solutions across therapeutics, medical technologies, diagnostics, and digital health. By providing critical, non-dilutive funding, the BMC helps transform high-risk, high-potential ideas into commercially viable products that address major healthcare challenges, improve patient outcomes, and drive economic growth.

Read more here.